Nanoparticle formation of an antimicrobial peptide induced by sulfated β-cyclodextrin: Application to alkaloid encapsulation
Year: 2025
Type: article
Abstract: • Dhvar4 peptide forms a strongly bound 1:1 inclusion complex with sulfobutyl ether β-cyclodextrin. • Sulfated β-cyclodextrin and Dhvar4 spontaneously self-assemble into highly stable nanoparticles. • Nanoparticles include coralyne and sanguinarine with efficiencies of 99% and 78%, respectively. • Each sulfated β-cyclodextrin could bind ∼13 molecules of these alkaloids. • The dimerization capability of the loaded alkaloid promotes its inclusion within the nanocarrier. The association of polyanionic β-cyclodextrin (βCD) derivatives with the nonaggregating polycationic antimicrobial peptide Dhvar4 was studied in water at 296 K without a buffer to explore their potential for forming nanoparticles capable of encapsulating bioactive isoquinoline alkaloids. The βCD bearing sulfobutyl ether moieties formed a 1:1 inclusion complex with Dhvar4, exhibiting a binding constant of (1.1 ± 0.3) × 10 5 M –1 . In contrast, βCD substituted with SO₃⁻ groups (S 13 βCD) promoted the self-assembly into nanoparticles with a narrow and uniform size distribution. When Dhvar4 was present in large excess relative to S 13 βCD, positively charged nanoparticles were produced. Conversely, negatively charged nanoparticles were obtained at S 13 βCD/Dhvar4 charge ratios above 2.5, which maintained their size for at least 30 days. The incorporation of pharmaceutically active isoquinoline alkaloids had minimal impact on the properties of nanoparticles formed in the presence of a >35 molar% excess of S 13 βCD over Dhvar4. Encapsulation efficiencies of 99% and 72% were achieved for coralyne and sanguinarine, respectively. Job plot and isothermal titration calorimetry measurements demonstrated that each S 13 βCD macrocycle could bind ∼13 molecules of these alkaloids. The present findings lay the groundwork for future biological validation and applications of nanoparticles composed of three types of biomedically important compounds.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,790
Awards: G2060704165, G528759016
OpenAlex ID: W4416678133
